Dermbits

Dermbits

Welcome to Dermbits! Watch short videos of KOLs answering your questions
How do you balance access realities with ideal treatment plans?
1:20
Jun 2, 2026Atopic Dermatitis

How do you balance access realities with ideal treatment plans?

-

How do you handle denials for FDA-approved therapies?
1:05
Jun 2, 2026Atopic Dermatitis

How do you handle denials for FDA-approved therapies?

-

How do you handle coverage for patients switching insurance mid-treatment?
1:16
Jun 2, 2026Atopic Dermatitis

How do you handle coverage for patients switching insurance mid-treatment?

-

What’s your approach when payer criteria conflict with clinical guidelines?
1:15
Jun 2, 2026Atopic Dermatitis

What’s your approach when payer criteria conflict with clinical guidelines?

-

What helps secure approval for ruxolitinib in patients with limited BSA?
0:59
Jun 2, 2026Atopic Dermatitis

What helps secure approval for ruxolitinib in patients with limited BSA?

-

How do you position ruxolitinib after partial response to prior therapy?
0:47
Jun 2, 2026Atopic Dermatitis

How do you position ruxolitinib after partial response to prior therapy?

-

What is the mechanism of action of apremilast?
1:46
Jun 1, 2026Psoriasis

What is the mechanism of action of apremilast?

-

In what scenarios do you find apremilast works best alongside other therapies rather than as monotherapy?
1:47
Jun 1, 2026Psoriasis

In what scenarios do you find apremilast works best alongside other therapies rather than as monotherapy?

-

What do dermatologists sometimes overlook about apremilast when focusing on newer therapies?
2:13
Jun 1, 2026Psoriasis

What do dermatologists sometimes overlook about apremilast when focusing on newer therapies?

-

What counseling strategies have made the biggest difference in helping patients get through the first few weeks on apremilast?
2:02
Jun 1, 2026Psoriasis

What counseling strategies have made the biggest difference in helping patients get through the first few weeks on apremilast?

-

How do functionally sensitive areas like hands, feet, or scalp change your threshold for moving beyond topicals?
1:36
Jun 1, 2026Psoriasis

How do functionally sensitive areas like hands, feet, or scalp change your threshold for moving beyond topicals?

-

Are we sometimes optimizing for BSA instead of optimizing for the patient’s lived experience?
2:42
Jun 1, 2026Psoriasis

Are we sometimes optimizing for BSA instead of optimizing for the patient’s lived experience?

-

What aspects of tapinarof’s AhR-driven mechanism are most clinically meaningful in AD?
1:16
May 26, 2026Atopic Dermatitis

What aspects of tapinarof’s AhR-driven mechanism are most clinically meaningful in AD?

-

Which efficacy outcomes with tapinarof for AD have proven most meaningful in your clinical experience?
1:56
May 26, 2026Atopic Dermatitis

Which efficacy outcomes with tapinarof for AD have proven most meaningful in your clinical experience?

-

Where does tapinarof fit in your current treatment approach for AD?
1:07
May 26, 2026Atopic Dermatitis

Where does tapinarof fit in your current treatment approach for AD?

-

Are there specific body areas or disease patterns in AD where tapinarof has been particularly useful?
0:49
May 26, 2026Atopic Dermatitis

Are there specific body areas or disease patterns in AD where tapinarof has been particularly useful?

-

Do you feel newer nonsteroidal topicals are being used to their full potential in clinical practice?
1:14
May 26, 2026Atopic Dermatitis

Do you feel newer nonsteroidal topicals are being used to their full potential in clinical practice?

-

How do you balance short-term AD control with steroids vs longer-term maintenance with nonsteroidal therapies?
1:46
May 26, 2026Atopic Dermatitis

How do you balance short-term AD control with steroids vs longer-term maintenance with nonsteroidal therapies?

-

When you’re introducing Cordran Tape to someone unfamiliar with it, how do you describe what it is in practical terms, both in terms of its physical form and how it functions on the skin?
1:40
May 22, 2026Topical Therapies

When you’re introducing Cordran Tape to someone unfamiliar with it, how do you describe what it is in practical terms, both in terms of its physical form and how it functions on the skin?

-

Can you walk through how you use the occlusive nature of Cordran Tape in practice, and how it changes your approach compared to standard topical steroids?
1:42
May 22, 2026Topical Therapies

Can you walk through how you use the occlusive nature of Cordran Tape in practice, and how it changes your approach compared to standard topical steroids?

-

Can you walk through a few of the highest-yield clinical scenarios where Cordran Tape really stands out, and what you’ve seen in terms of outcomes?
1:01
May 22, 2026Topical Therapies

Can you walk through a few of the highest-yield clinical scenarios where Cordran Tape really stands out, and what you’ve seen in terms of outcomes?

-

With so many newer topical options available, where do you see Cordran Tape fitting into current treatment approaches?
1:04
May 22, 2026Topical Therapies

With so many newer topical options available, where do you see Cordran Tape fitting into current treatment approaches?

-

In your experience, what are the common reasons traditional topical therapies fall short in certain patients or lesions?
0:55
May 22, 2026Topical Therapies

In your experience, what are the common reasons traditional topical therapies fall short in certain patients or lesions?

-

Are there any older dermatologic therapies or approaches that you feel are underutilized today, and why do you think they’ve been overlooked?
1:17
May 22, 2026Topical Therapies

Are there any older dermatologic therapies or approaches that you feel are underutilized today, and why do you think they’ve been overlooked?

-